WallStreetZenWallStreetZen

NASDAQ: GHSI
Guardion Health Sciences Inc Stock

$8.07+0.22 (+2.8%)
Updated Apr 17, 2024
GHSI Price
$8.07
Fair Value Price
N/A
Market Cap
$10.36M
52 Week Low
$5.01
52 Week High
$10.75
P/E
67.25x
P/B
1.27x
P/S
0.55x
PEG
N/A
Dividend Yield
N/A
Revenue
$12.25M
Earnings
$158.03k
Gross Margin
44%
Operating Margin
1.29%
Profit Margin
1.3%
Debt to Equity
0.46
Operating Cash Flow
-$4M
Beta
0.5
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

GHSI Overview

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GHSI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GHSI is poor value based on its earnings relative to its share price (67.25x), compared to the US market average (41.64x)
P/E vs Market Valuation
GHSI is poor value based on its earnings relative to its share price (67.25x), compared to the US Drug Manufacturers - Specialty & Generic industry average (47.05x)
P/E vs Industry Valuation
GHSI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more GHSI due diligence checks available for Premium users.

Be the first to know about important GHSI news, forecast changes, insider trades & much more!

GHSI News

Valuation

GHSI fair value

Fair Value of GHSI stock based on Discounted Cash Flow (DCF)
Price
$8.07
Fair Value
-$7.83
Undervalued by
203.09%

GHSI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
67.25x
Industry
47.05x
Market
41.64x
GHSI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
GHSI is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

GHSI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.27x
Industry
2.04x
GHSI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GHSI's financial health

Profit margin

Revenue
$2.9M
Net Income
$424.7k
Profit Margin
14.5%
GHSI's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
GHSI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$11.9M
Liabilities
$3.8M
Debt to equity
0.46
GHSI's short-term assets ($11.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GHSI's short-term assets ($11.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GHSI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
GHSI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.3M
Investing
$19.9k
Financing
$0.0
GHSI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GHSI vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
GHSI$10.36M+2.80%67.25x1.27x
BFRI$8.70M-5.99%-0.13x1.82x
COSM$8.44M-1.87%-0.15x0.19x
CLVR$7.42M-6.83%-0.37x0.31x
UPC$7.40M+8.56%-1.19x0.19x

Guardion Health Sciences Stock FAQ

What is Guardion Health Sciences's quote symbol?

(NASDAQ: GHSI) Guardion Health Sciences trades on the NASDAQ under the ticker symbol GHSI. Guardion Health Sciences stock quotes can also be displayed as NASDAQ: GHSI.

If you're new to stock investing, here's how to buy Guardion Health Sciences stock.

What is the 52 week high and low for Guardion Health Sciences (NASDAQ: GHSI)?

(NASDAQ: GHSI) Guardion Health Sciences's 52-week high was $10.75, and its 52-week low was $5.01. It is currently -24.93% from its 52-week high and 61.08% from its 52-week low.

How much is Guardion Health Sciences stock worth today?

(NASDAQ: GHSI) Guardion Health Sciences currently has 1,284,156 outstanding shares. With Guardion Health Sciences stock trading at $8.07 per share, the total value of Guardion Health Sciences stock (market capitalization) is $10.36M.

Guardion Health Sciences stock was originally listed at a price of $1,104.00 in Apr 5, 2019. If you had invested in Guardion Health Sciences stock at $1,104.00, your return over the last 5 years would have been -99.27%, for an annualized return of -62.61% (not including any dividends or dividend reinvestments).

How much is Guardion Health Sciences's stock price per share?

(NASDAQ: GHSI) Guardion Health Sciences stock price per share is $8.07 today (as of Apr 17, 2024).

What is Guardion Health Sciences's Market Cap?

(NASDAQ: GHSI) Guardion Health Sciences's market cap is $10.36M, as of Apr 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Guardion Health Sciences's market cap is calculated by multiplying GHSI's current stock price of $8.07 by GHSI's total outstanding shares of 1,284,156.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.